- Docente: Domenico Motola
- Credits: 2
- SSD: BIO/14
- Language: Italian
- Teaching Mode: Traditional lectures
- Campus: Bologna
- Corso: Second cycle degree programme (LM) in Nursing and Midwifery Sciences (cod. 8488)
Learning outcomes
At the end of the course, the student must have the knowledge and skills to understand the work processes of health organizations in order to promote the achievement of safe, effective, efficient, relevant, culture-sensitive, appropriately documented and provided by competent staff in particular on pharmacovigilance issues related to nursing and midwifery.
Course contents
1) The clinical development of drugs and marketing authorization (MA) procedures.
2) Therapeutic innovation of drugs: classification and examples.
3) The surveillance of adverse drug reactions in daily practice.
4) Drug-drug interactions.
5) To prevent errors in therapy: classification and examples.
6) Scientific and regulatory issues and place in therapy for generic drugs and biosimilars.
7) The national and regional pharmaceutical handbook with notes on the classification of drugs according to their prescribing and reimbursement.
8) Factors affetting inter-individual variations in drug responses: the pharmacogenetics.
Readings/Bibliography
Slides and lecture notes.
Teaching methods
Lectures in the classroom and online. Resolutions of clinical cases.
Assessment methods
The assessment of the knowledge gained by the student is based on the administration of a questionnaire consisting of 31 questions, with true/false answer, equally distributed among the 9 topics of the programme.
Teaching tools
Video-projector
Office hours
See the website of Domenico Motola
SDGs
This teaching activity contributes to the achievement of the Sustainable Development Goals of the UN 2030 Agenda.